Replies to post #3145 on Acadia Pharmaceuticals Inc. (ACAD)

[IanFromSI]

And here's one from only 2 days ago...


ACADIA Pharmaceuticals (ACAD) Gets a Buy Rating from SVB Securities
July 11 2022 - 08:39AM

In a report released today, Marc Goodman from SVB Securities maintained a Buy rating on ACADIA Pharmaceuticals (ACAD – Research Report), with a price target of $27.00. The company's shares closed last Friday at $15.74.

ACADIA Pharmaceuticals has an analyst consensus of Moderate Buy, with a price target consensus of $22.64, representing a 45.7% upside.
https://www.tipranks.com/news/blurbs/acadia-pharmaceuticals-acad-gets-a-buy-rating-from-svb-securities?utm_source=advfn.com&utm_medium=referral